إعلان
إعلان
CORT
Corcept Therapeutics Inc.
37.50
USDبرعاية
+0.97
+2.65%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
37.19
-0.31
-0.83%
تقارير أرباح CORT
النسبة الإيجابية المفاجئة
CORT تفوق 26 من 40 آخر التقديرات.
65%
التقرير التالي
بيانات التقرير القادم
٢٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$266.35M
/$0.34
التغير الضمني من Q3 25 (Revenue/ EPS)
+28.28%
/+112.50%
التغير الضمني من Q4 24 (Revenue/ EPS)
+46.43%
/+30.77%
Corcept Therapeutics Inc. earnings per share and revenue
On ٠٤ نوفمبر ٢٠٢٥, CORT reported earnings of 0.16 USD per share (EPS) for Q3 25, beating the estimate of 0.13 USD, resulting in a 16.19% surprise. Revenue reached 207.64 مليون, compared to an expected 222.90 مليون, with a -6.85% difference. The market reacted with a +7.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 المحللين forecast an EPS of 0.34 USD, with revenue projected to reach 266.35 مليون USD, implying an زيادة of 112.50% EPS, and زيادة of 28.28% in Revenue from the last quarter.
الأسئلة الشائعة
What were Corcept Therapeutics Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Corcept Therapeutics Inc. reported EPS of $0.16, beating estimates by 16.19%, and revenue of $207.64M, -6.85% below expectations.
How did the market react to Corcept Therapeutics Inc.'s Q3 2025 earnings?
The stock price moved up 7.81%, changed from $71.10 before the earnings release to $76.65 the day after.
When is Corcept Therapeutics Inc. expected to report next?
The next earning report is scheduled for ٢٤ فبراير ٢٠٢٦.
What are the forecasts for Corcept Therapeutics Inc.'s next earnings report?
Based on 8
المحللين, Corcept Therapeutics Inc. is expected to report EPS of $0.34 and revenue of $266.35M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان